Can The Time Needed for CAR-T be shortened? EXUMA Says Yes!!! Dr. Gregory Frost, CEO, EXUMA Biotech

episode

BioTech Nation ... with Dr. Moira Gunn not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Could sofa theory help you find your ideal partner? 4 min · 23 Sep 2026 · Do you really know?

Behind The Scenes At Vogue World Milano 28 min · 23 Sep 2026 · The Run-Through with Vogue

Is end-to-end encryption really secure? 4 min · 23 Sep 2026 · Do you really know?

Do tongue scrapers actually help with bad breath? 5 min · 23 Sep 2026 · Do you really know?

Lab Notes: Have we found dark matter? 10 min · 23 Sep 2026 · The Science Show

Is it cool to have no friends? 26 min · 23 Sep 2026 · Today in Focus

Report any issue

Source

Recorded26 Jul 2023

Publisherfeeds.transistor.fm ↗

Handlerec:13349852

Show notes

In this week's episode of Biotech Nation, Dr. Greg Frost, CEO of Exuma Biotech, discusses their innovative approaches to cancer treatment. They are working on a method to shorten the time and eliminate hospital stays for CAR-T therapy, while also developing a new technology called G-car that combines T cells and NK cells to create a more gentle and effective cancer therapy.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in